EUVIMEDEUVIMED entdecken
Crossref

Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long‐term complications of inadequate immunosuppression

Luc Chauvelot, Thomas Barba, Carole Saison, Evangelia Siska, Dorian Kulifaj iD, Stephan J L Bakker, Alice Koenig, Maud Rabeyrin, Fanny Buron, Cécile Picard, Frédérique Dijoud, Louis Manière und 4 weitere

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Luc Chauvelot und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Groupement Hospitalier Centre, Lyon, France. Hauptthemen laut MEDLINE: Torque teno virus, Kidney Transplantation, DNA, Viral, Transplant Recipients. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: bioMérieux, Luc Chauvelot received a fellowship "année recherche" from the Hospices Civils de Lyon. Thomas Barba is supported by INSERM (poste accueil 2016), and the Hospi….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimization of individual immunosuppression, which reduces the risks of both graft loss and patients' death, is considered the best approach to improve long‐term outcomes of renal transplantation. Torque Teno Virus (TTV) DNAemia has emerged as a potential biomarker reflecting the depth of therapeutic immunosuppression during the initial year post‐transplantation. However, its efficacy in long‐term monitoring remains uncertain. In a cohort study involving 34 stable kidney transplant recipients and 124 healthy volunteers, we established lower and upper TTV DNAemia thresholds (3.75–5.1 log10 cp/mL) correlating with T‐cell activatability, antibody response against flu vaccine, and risk for subsequent serious infections or cancer over 50 months. Validation in an independent cohort of 92 recipients confirmed that maintaining TTV DNAemia within this range in >50% of follow‐up time points was associated with reduced risks of complications due to inadequate immunosuppression, including de novo DSA, biopsy‐proven antibody‐mediated rejection, graft loss, infections, or cancer. Multivariate analysis highlighted “in‐target” TTV DNAemia as the sole independent variable significantly linked to decreased risk for long‐term complications due to inadequate immunosuppression (odds ratio [OR]: 0.27 [0.09–0.77]; p = 0.019). Our data suggest that the longitudinal monitoring of TTV DNAemia in kidney transplant recipients could help preventing the long‐term complications due to inadequate immunosuppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Torque teno virusKidney TransplantationDNA, ViralTransplant RecipientsDNA Virus InfectionsImmunosuppression TherapyHumansMaleFemaleMiddle AgedAdultLongitudinal StudiesAgedGraft RejectionImmunosuppressive AgentsCohort StudiesViremia

Stichwörter der Autor:innen

DSATTVbiomarkercancerinfectionkidney transplantationtherapeutic immunosuppression

Substanzen

DNA, ViralImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Groupement Hospitalier Centre, Lyon, France.
  • CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
  • Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon, France.
  • Department of Internal Medicine, Hospices Civils de Lyon, Groupement Hospitalier Centre, Lyon, France.
  • French National Blood Service (EFS), HLA Laboratory, Lyon, France.
  • BioMérieux SA, 138, Rue Louis PASTEUR, Parc Technologique Delta Sud, Verniolle, France.

ORCID-Profile: Dorian Kulifaj, Olivier Thaunat

Förderung

  • bioMérieux
  • Luc Chauvelot received a fellowship "année recherche" from the Hospices Civils de Lyon. Thomas Barba is supported by INSERM (poste accueil 2016), and the Hospi…

Zitieren

APA

Chauvelot, L., Barba, T., Saison, C., Siska, E., Kulifaj, D., Bakker, S. J. L., Koenig, A., Rabeyrin, M., Buron, F., Picard, C., Dijoud, F., Manière, L., Lina, B., Morelon, E., Dubois, V., & Thaunat, O. (2024). Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long‐term complications of inadequate immunosuppression. Journal of Medical Virology. https://doi.org/10.1002/jmv.29806

Vancouver

Chauvelot L, Barba T, Saison C, Siska E, Kulifaj D, Bakker SJL, et al. Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long‐term complications of inadequate immunosuppression. Journal of Medical Virology. 2024. doi:10.1002/jmv.29806

BibTeX
@article{Chauvelot2024,
  author = {Chauvelot, Luc and Barba, Thomas and Saison, Carole and Siska, Evangelia and Kulifaj, Dorian and Bakker, Stephan J L and Koenig, Alice and Rabeyrin, Maud and Buron, Fanny and Picard, Cécile and Dijoud, Frédérique and Manière, Louis and Lina, Bruno and Morelon, Emmanuel and Dubois, Valerie and Thaunat, Olivier},
  title = {Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long‐term complications of inadequate immunosuppression},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29806}
}
Kostenlos starten →